In addition, 7% of Rnf8−/−p53+/− mice (1 out of 15) developed rhabdomyosarcoma (Figure 9C) and lung adenocarcinoma (Figure 9D). This evidence concerns the gene RNF8 and rhabdomyosarcoma.